EFFECT OF CANDESARTAN ON PARAMETERS OFDAILYBLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEYDISEASE ON HEMODIALYSIS
Introduce.Advances of normal blood pressure in patients on program hemodialysis presented a serious problem related disciplines. For verification hypertension used routine blood pressure measurement and ambulatory monitoring to control the pressure in interdialytic time, which is an important predi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
National Kidney Foundation of Ukraine
2017-12-01
|
| Series: | Український Журнал Нефрології та Діалізу |
| Subjects: | |
| Online Access: | https://ukrjnd.com.ua/index.php/journal/article/view/40 |
| Summary: | Introduce.Advances of normal blood pressure in patients on program hemodialysis presented a serious problem related disciplines. For verification hypertension used routine blood pressure measurement and ambulatory monitoring to control the pressure in interdialytic time, which is an important predictor of cardiovascular events among these patients.
The aim of research was to investigate features ofparameters the ambulatory monitoring of blood pressure in the dynamics after treatment of candesartan in patients receiving renal replacement therapy.
Materials and methods: 53patients ongoing chronic hemodialysis were makethe ambulatory monitoring of blood pressure before and after 12–weeks treatment of candesartan (4–32 mg).
Results. It was established that the prevalence of hypertension in a population of patients on hemodialysis influenced by candesartan treatment decreased from 53.6 % to 32.1 %. Patients on hemodialysis in 75 % of cases have incresedpulse pressure (> 60 mm Hg), the percentage of which after therapy decreased to 51.8. Prevailing type of daily blood pressure as the treatment and after treatment is «non–dipper». Established that candesartan showed a positive effect in relation to a statistically significant reduction in the average time indices and blood pressure
Conclusion: results of the study allowtorecommend candesartan for treatment of hypertension in hemodialysis patients.
|
|---|---|
| ISSN: | 2304-0238 2616-7352 |